Description
What this story covers
Xylem Inc. reported 7 point 4 billion dollars revenue in 2023, up 33 percent via Evoqua acquisition, with 12 point 5 percent organic growth across segments. Backlog hit 5 point 1 billion dollars, adjusted EBITDA margin rose to 18 point 9 percent. Strategy emphasizes innovation, sustainability, and emerging markets amid water challenges. 2024 outlook: 14 to 15 percent growth. Risks include supply chains, competition, cybersecurity.
Story snapshot
CompanyXylem Inc.
TickerXYL
VariantStandard detailed
Duration25:15
Filing type10-K
PeriodAnnual 2023
IndustryIndustrials & Manufacturing
Accession0001524472-24-000006
Full Story Script
Content not available for this story.
